Kawa · Diabetes & metabolic syndrome 2021 · narrative review · n=?

Endocrine disrupting chemical Bisphenol A and its potential effects on female health.

Cited 170 times in the scientific literature.

Level 5 - mechanism / opinion, no new human data

Narrative review without formal systematic review methodology or meta-analysis

PubMed 33839640 · doi:10.1016/j.dsx.2021.03.031 · record verified 2026-08-28

What was done

The authors performed a narrative literature survey using PubMed and Google Scholar with targeted keywords to review evidence on the effects of endocrine-disrupting chemicals, particularly bisphenol A (BPA), on female reproduction and polycystic ovary syndrome (PCOS).

What was found

The abstract reports no numerical findings, effect sizes, or counts. It describes qualitative associations between EDC/BPA exposure and female reproductive abnormalities, including menstrual irregularities, impaired fertility, PCOS, and endometriosis, and notes potential early-life and transgenerational effects.

Why it matters

Because BPA is widely used in plastics and resins, synthesizing its links to prevalent reproductive disorders highlights environmental contributors to female endocrine dysfunction.

Limits

The abstract provides no quantitative data, sample sizes, or formal systematic review methodology (e.g., PRISMA protocol, explicit inclusion criteria, or risk-of-bias assessment). Distinctions between human clinical evidence and preclinical mechanism data are not reported in the abstract.

Cited by